1.Progress in mechanism of quercetin alleviating nonalcoholic fatty liver disease
Lianghao LIU ; Qingliang SONG ; Maoxing PAN ; Yupei ZHANG
Chinese Journal of Pathophysiology 2025;41(9):1832-1838
Nonalcoholic fatty liver disease(NAFLD)is the chronic liver disease with the highest global preva-lence.It has multiple causes and complex mechanisms,and its prevalence is increasing year by year.Currently,there are still no drugs that are widely promoted and used.Quercetin possesses multiple pharmacological activities such as antioxida-tion,anti-inflammation,lipid-lowering and regulation of intestinal flora.Recent studies have shown that it can intervene in the progression of NAFLD through multiple pathways,including anti-inflammation,promotion of autophagy,inhibition of oxidative stress,attenuation of insulin resistance,regulation of endoplasmic reticulum stress and improvement of cogni-tion.In addition,quercetin can also inhibit diabetes mellitus complicated with NAFLD lesions.This article reviews the mechanism by which quercetin alleviates NAFLD,with the aim of providing a reference for the clinical prevention and treatment of NAFLD.
2.Clinical phenotype and genetic analysis of a child with CAKUTHED syndrome due to variant of PBX1 gene.
Jiao TANG ; Chuan ZHANG ; Ruiqiong YANG ; Xinyuan TIAN ; Bingbo ZHOU ; Yupei WANG ; Ling HUI
Chinese Journal of Medical Genetics 2025;42(12):1471-1476
UNLABELLED:
OBJECTIVE:To explore the clinical characteristics and genetic etiology of a child with CAKUTHED syndrome.
METHODS:
A child who was admitted to the neonatal department of Gansu Provincial Maternal and Child Health Care Hospital due to "neonatal asphyxia" in May 2021 was selected as the study subject. Genomic DNA was extracted from peripheral venous blood samples from the child and his parents, and whole exome sequencing (WES) was carried out. Sanger sequencing was used to verify the candidate variant of the PBX1 gene. Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), the pathogenicity of candidate variants was rated. This study was approved by the Medical Ethics Committee of the Hospital [Ethics No.: 2021GSFY (65)].
RESULTS:
The proband, a male neonate, manifested renal dysplasia, congenital heart disease, pulmonary dysplasia, mediastinal hernia, cryptorchidism, and clavicle dysplasia. WES revealed that he had harbored a heterozygous c.863G>A (p.Arg288Gln) missense variant in exon 6 of PBX1 gene, which resulted substitution of Arginine at position 288 by Glutamine, for which both parents were of the wild type. The variant was unreported previously and rated as pathogenic (PS2+PM1+PM2_Supporting+PP2+PP3) based on the ACMG guidelines.
CONCLUSION
The c.863G>A variant of the PBX1 gene probably underlay the pathogenesis in the proband. Above finding has enriched the mutational spectrum of the PBX1 gene.
Humans
;
Male
;
Pre-B-Cell Leukemia Transcription Factor 1/genetics*
;
Phenotype
;
Infant, Newborn
;
Exome Sequencing
;
Mutation, Missense
;
Heart Defects, Congenital/genetics*
;
Abnormalities, Multiple/genetics*
3.Progress in mechanism of quercetin alleviating nonalcoholic fatty liver disease
Lianghao LIU ; Qingliang SONG ; Maoxing PAN ; Yupei ZHANG
Chinese Journal of Pathophysiology 2025;41(9):1832-1838
Nonalcoholic fatty liver disease(NAFLD)is the chronic liver disease with the highest global preva-lence.It has multiple causes and complex mechanisms,and its prevalence is increasing year by year.Currently,there are still no drugs that are widely promoted and used.Quercetin possesses multiple pharmacological activities such as antioxida-tion,anti-inflammation,lipid-lowering and regulation of intestinal flora.Recent studies have shown that it can intervene in the progression of NAFLD through multiple pathways,including anti-inflammation,promotion of autophagy,inhibition of oxidative stress,attenuation of insulin resistance,regulation of endoplasmic reticulum stress and improvement of cogni-tion.In addition,quercetin can also inhibit diabetes mellitus complicated with NAFLD lesions.This article reviews the mechanism by which quercetin alleviates NAFLD,with the aim of providing a reference for the clinical prevention and treatment of NAFLD.
4.Clinical manifestation and genetics analysis of hereditary spastic paraplegia families
Chuan ZHANG ; Ling HUI ; Bingbo ZHOU ; Lei ZHENG ; Yupei WANG ; Xinyuan TIAN ; Panpan MA ; Shengju HAO ; Zhenqiang DA
Chinese Journal of Nervous and Mental Diseases 2025;51(3):129-134
Objective To analyze the clinical manifestations and genetic etiology of three families with hereditary spastic paraplegia(HSP).Methods Gene analysis was performed on patients of the three HSP families from the Gansu Provincial Maternity and Child-care Hospital.Results The proband of family 1 was autosomal recessive spastic paraplegia type 35 caused by homozygous variant c.159_176delGGCGGGCCAGGACATCAG(p.Arg53_Ser59delinsSer)in FA2H.The proband in family 2 was autosomal recessive spastic paraplegia type 47 caused by homozygous variant c.1399G>T(p.Glu467Ter)in AP4B1,and the proband in family 3 was autosomal recessive spastic paraplegia type 11 caused by homozygous variation c.7023C>G(p.Tyr2341Ter)in SPG11.Among them,the variant c.1399G>T(p.Glu467Ter)of AP4B1 is a novel variant,that has not been reported before,according to the ACMG guidelines,the pathogenicity of this variant is pathogenic.Conclusion This study has expanded the variant spectrum of AP4B1 which provides basic data to improve clinical understanding and diagnostic capabilities of HSP patients.
5.Clinical manifestation and genetics analysis of hereditary spastic paraplegia families
Chuan ZHANG ; Ling HUI ; Bingbo ZHOU ; Lei ZHENG ; Yupei WANG ; Xinyuan TIAN ; Panpan MA ; Shengju HAO ; Zhenqiang DA
Chinese Journal of Nervous and Mental Diseases 2025;51(3):129-134
Objective To analyze the clinical manifestations and genetic etiology of three families with hereditary spastic paraplegia(HSP).Methods Gene analysis was performed on patients of the three HSP families from the Gansu Provincial Maternity and Child-care Hospital.Results The proband of family 1 was autosomal recessive spastic paraplegia type 35 caused by homozygous variant c.159_176delGGCGGGCCAGGACATCAG(p.Arg53_Ser59delinsSer)in FA2H.The proband in family 2 was autosomal recessive spastic paraplegia type 47 caused by homozygous variant c.1399G>T(p.Glu467Ter)in AP4B1,and the proband in family 3 was autosomal recessive spastic paraplegia type 11 caused by homozygous variation c.7023C>G(p.Tyr2341Ter)in SPG11.Among them,the variant c.1399G>T(p.Glu467Ter)of AP4B1 is a novel variant,that has not been reported before,according to the ACMG guidelines,the pathogenicity of this variant is pathogenic.Conclusion This study has expanded the variant spectrum of AP4B1 which provides basic data to improve clinical understanding and diagnostic capabilities of HSP patients.
6.Recent Advances in Meridian and Acupoint Detection
Yupei CHENG ; Yang GUO ; Runchen ZHANG ; Yi GUO ; Bangqi WU
World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(2):329-336
This paper summarized and analyzed various characteristics of meridians and acupoints and their detection technologies in the past 5 years,which screened on PubMed,CNKI(China National Knowledge Infrastructure)database,and Wanfang database.Current studies are primarily focus on the electrical,thermal,and optical characteristics of meridians and acupoints.Utilizing modern technology,devices designed to detect these characteristics have been applied in selecting acupoints,assisting diagnosis,reflecting the effectiveness of acupuncture,and conducting health assessments.The use of external detection devices to explore the physical properties of meridians and acupoints provides more precise technical feedback for substantial research into these areas.However,future efforts must strengthen the comprehensive exploration of meridian and acupoint characteristics and foster interdisciplinary technological integration.This approach will enable a positive development cycle of"detection-feedback-relearning"in the research of meridian and acupoint characteristics.
7.Systemic lupus erythematosus related thrombotic microangiopathy: A retrospective study based on Chinese SLE Treatment and Research Group (CSTAR) registry.
Yupei ZHANG ; Nan JIANG ; Zhen CHEN ; Xinwang DUAN ; Xiaofei SHI ; Hongbin LI ; Zhenyu JIANG ; Yuhua WANG ; Yanhong WANG ; Jiuliang ZHAO ; Qian WANG ; Xinping TIAN ; Mengtao LI ; Xiaofeng ZENG
Chinese Medical Journal 2025;138(5):613-615
8.Advances and thoughts in the diagnosis and treatment of pancreatic cancer
Yueze LIU ; Taiping ZHANG ; Yupei ZHAO
Journal of Clinical Hepatology 2025;41(4):601-604
In recent years, significant progress has been made in the standardized diagnosis and treatment of pancreatic cancer in China. From the lack of treatment options and poor drug efficacy at the beginning to the current comprehensive treatment modality integrating surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapy under multidisciplinary decision-making, the diagnosis and treatment of pancreatic cancer has gradually achieved higher levels of individualization, refinement, and precision. With reference to the latest evidence-based medical data, this article discusses the hot topics in the diagnosis and treatment of pancreatic cancer and explores the future development directions of this field.
9.Exploration of the mechanism of metformin's mherapeutic effect on mice with Beh?et's disease-like symptoms
Jing ZHAO ; Yanjuan CHEN ; Anmao LI ; Yupei LIN ; Mei TIAN ; Yanlin ZHANG ; Yong CHEN
Chinese Journal of Rheumatology 2025;29(8):633-638
Objective:To investigate the impact of metformin on the Beh?et's disease (BD) mice model via the Treg/Th17 axis.Methods:The BD mice model was established by subcutaneous injection of HSV-1. Four groups were established, including healthy control group, model group, high-dose metformin group, and low-dose metformin group. The HSV-1 DNA copy number in the peripheral blood was measured using qRT-PCR. Plasma levels of TGF-β 1, IL-10, IL-17, IL-23, IL-6, and TNF-α were assessed by ELISA. Flow cytometry was employed to determine the proportion of Treg and Th17 cells in the spleen. One-way analysis of variance was used for inter-group comparisons, pairwise comparisons were performed using SNK- q test. Results:Thirty-eight BD models were successfully established, with 28 survived. Compared to the BD model group, the metformin treatment groups showed faster healing of genital ulcers, joint redness/swelling, and skin ulcers, along with better mental status. HSV-1 copy numbers decreased in the metformin groups compared to the model group at 20 and 30 days post-treatment. Compared to the healthy control group, the model group exhibited elevated levels of TGF-β 1, IL-17, IL-6, IL-23, and TNF-α, but a decrease in IL-10. Following high-dose metformin treatment, TGF-β 1, IL-17, IL-6, IL-23, and TNF-α were significantly reduced ( q=16.17, P<0.001; q=8.76, P<0.001; q=6.78, P=0.004; q=4.45, P=0.020; q=12.08, P<0.001), accompanied by elevated IL-10 (specific value) ( q=6.28, P<0.001). Compared with the control group [Treg: (1.82±0.68)%; Th17: (2.12±0.86)%], the model group showed significantly elevated proportions of Treg cells[(6.03±2.42)%] ( q=5.01, P<0.001) and Th17 cell [(3.40±0.58)%] ( q=2.96, P=0.017). After high-dose metformin treatment, both Treg cell proportion [(3.20±1.66)%] and Th17 cell proportion [(2.16±0.78)%] decreased compared to the model group ( q=3.05, P=0.014). No significant differences were observed between the high-and low-dose metformin groups across all measured indicators, indicating similar efficacy. Conclusion:Metformin could reduce HSV-1 virus replication, reduce the levels of inflammatory cytokines and regulate Treg/Th17 axis to alleviate the BD symptoms. This study provides evidence for repurposing metformin in the treatment of Beh?et's disease.
10.Mass spectrometry screening and genetic diagnosis of β-ketothiolase deficiency
Jiandang LI ; Yuhan CHEN ; Lei YAN ; Huilin HAN ; Yupei ZHANG ; Wanqiao ZHANG
The Journal of Practical Medicine 2025;41(3):422-427
Objective To assess the efficacy of tandem mass spectrometry-specific indicators in diagnosing β-ketothiolase deficiency(BKD)and to elucidate the associated gene variations contributing to the corresponding pathogenic phenotype,thereby facilitating rapid and accurate diagnosis of BKD.Methods Data from tandem mass spectrometry(MS/MS)screening of dried blood spots collected from 16,071 children between January 2018 and December 2021,along with results from gas chromatography-mass spectrometry(GC-MS)analysis and high-throughput sequencing of positive cases,were analyzed retrospectively.The study aimed to evaluate the contribution of specific MS/MS indicators in the clinical diagnosis of BKD and to trace the genetic etiology of this disease.Results Among the 16 071 subjects screened by MS/MS,37 cases(2.30‰)exhibited elevated C5OH levels,41 cases(2.55‰)showed increased C5∶1 levels,and 2 cases were diagnosed with BKD based on GC-MS analysis.When diagnosing BKD using C5OH as a single indicator,the false positive rate was 0.22%,which is lower than that of C5∶1(0.24%).The positive predictive value for C5OH was 5.40%,higher than that of C5∶1(4.88%).Among the 16 071 pediatric patients,only 2 cases were diagnosed with BKD due to elevated C5OH combined with increased C5∶1 levels,resulting in a positive predictive value of 100%.Whole exome sequencing of these two BKD patients revealed that both carried acetyl-CoA acetyltransferase 1(ACAT1)gene double allele missense heterozygous mutations.The four previously unreported mutation sites were c.949G>C(p.Asp317His),c.1063G>A(p.Ala355Thr),c.146G>A(p.Arg49Lys),and c.700G>A(p.Glu234Lys).These findings provide novel insights into the genetic basis of BKD.Conclusions The MS/MS screening indicator C5OH demonstrates superior diagnostic efficacy compared to C5∶1 in diagnosing BKD,as evidenced by lower false positive rates and higher positive predictive values.When diagnosing BKD,the use of combined indicators significantly enhances the accuracy of biochemical diagnosis compared to single indicators.Exome sequencing revealed that all BKD patients carried previously unreported mutations in the ACAT1.

Result Analysis
Print
Save
E-mail